InvestorsHub Logo
Followers 22
Posts 2285
Boards Moderated 0
Alias Born 01/02/2003

Re: None

Tuesday, 03/14/2017 9:22:38 AM

Tuesday, March 14, 2017 9:22:38 AM

Post# of 144
Editas bags $90M in gene editing R&D pact with Allergan
Editas Medicine has struck a research and development deal with Allergan under which the Cambridge-based gene editing firm will receive $90 million up front in exchange for giving the Irish drugmaker the option to license up to five programs targeting eye disease.
http://www.bizjournals.com/boston/news/2017/03/14/editas-bags-90m-in-gene-editing-r-d-pact-with.html


Editas Medicine (EDIT) Stock: Gaining Big On Allergan (AGN) Deal
http://cnafinance.com/editas-medicine-edit-stock-gaining-big-on-allergan-agn-deal/14193
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EDIT News